Analytical Data
-
Gene name
CNO
- Application
-
Alternative Names
BLOC1S4; CNOBiogenesis of lysosome-related organelles complex 1 subunit 4; BLOC-1 subunit 4; Protein cappuccino homolog
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9NUP1
-
Expression Region
1-217aa
-
AA Sequence
MEGSFSDGGA LPEGLAEEAE PQGAAWSGDS GTVSQSHSSA SGPWEDEGAE DGAPGRDLPL LRRAAAGYAA CLLPGAGARP EVEALDASLE DLLTRVDEFV GMLDMLRGDS SHVVSEGVPR IHAKAAEMRR IYSRIDRLEA FVRMVGGRVA RMEEQVTKAE AELGTFPRAF KKLLHTMNVP SLFSKSAPSR PQQAGYEAPV LFRTEDYFPC CSERPQL
-
Molecular Weight
23.3 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CNO, or the cyclin-dependent kinase inhibitor p18, is a crucial protein that plays a significant role in cell cycle regulation and differentiation. Its study has gained prominence due to its involvement in various cellular processes, including the inhibition of cyclin-dependent kinases (CDKs), which are essential for cell division. Dysregulation of CDK activity is associated with numerous diseases, particularly cancer, making CNO a potential target for therapeutic interventions. Research into the structure and function of CNO has revealed its intricate regulatory mechanisms, as well as its interactions with other cellular proteins. Understanding the nuances of CNO’s role in cellular physiology can provide insights into the underlying pathways involved in tumorigenesis and help in the development of novel cancer treatments. Additionally, the exploration of CNO as a recombinant protein has opened avenues for biotechnological applications, such as the development of diagnostic tools and targeted therapies. As the field progresses, the focus on CNO and its related pathways will likely yield significant advancements in both basic and applied biomedical research.











